Search results
Down -17.88% in 4 Weeks, Here's Why Ocular Therapeutix (OCUL) Looks Ripe for a Turnaround
Zacks via Yahoo Finance· 3 weeks agoOcular Therapeutix (OCUL) has become technically an oversold stock now, which implies exhaustion of...
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Intrinsic Value Is Potentially 32% Above Its Share Price
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Ocular Therapeutix's estimated fair value is US$8.20 based on 2 Stage Free Cash Flow to...
Are You Looking for a Top Momentum Pick? Why Ocular Therapeutix (OCUL) is a Great Choice
Zacks via Yahoo Finance· 2 months agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
What Makes Ocular Therapeutix (OCUL) a Good Fit for 'Trend Investing'
Zacks via Yahoo Finance· 1 year agoOcular Therapeutix (OCUL) could be a solid choice for shorter-term investors looking to capitalize...
With 48% stake, Ocular Therapeutix, Inc. (NASDAQ:OCUL) seems to have captured institutional...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Ocular Therapeutix, Inc. (NASDAQ:OCUL) should be aware of the most powerful...
Ocular (OCUL) Announces Positive Data on Wet AMD Candidate
Zacks via Yahoo Finance· 2 years agoOcular (OCUL) interim seven-month data on OTX-TKI from a phase I study for treating wet age-related...
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) 72% Price Boost Is Out Of Tune With Revenues
Simply Wall St. via Yahoo Finance· 4 months agoOcular Therapeutix, Inc. (NASDAQ:OCUL) shareholders would be excited to see that the share price has...
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoOcular Therapeutix (OCUL) delivered earnings and revenue surprises of 12% and 12.26%, respectively,...
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) large institutional owners must be happy as stock continues...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significantly high institutional ownership implies Ocular Therapeutix's stock price is...
Ocular Therapeutix (OCUL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 months agoOcular Therapeutix (OCUL) possesses the right combination of the two key ingredients for a likely...